|
Protocol Number:
84-M-0050
- Title:
Biochemical, Physiological, and Psychological Measures in Normal Controls and Relatives of Psychiatric Patients
- Number:
84-M-0050
- Summary:
A study of children and adolescents (current N=48) with very early onset by age 12 (COS) of DSM-III-R defined schizophrenia with (97-M-0126) is examining the clinical, neurobiological, early neurodevelopmental, genetic, and clinical drug response characteristics of these cases. Earlier studies have documented the continuity between COS and adult onset cases (See Jacobsen and Rapoport, 1998 for review). The focus has now shifted to increasing the sample size and evaluation of familial risk factors including: psychiatric diagnoses of family members; smooth pursuit eye movements; neuropsychological tests deficits, and obtaining blood for cell lines for genetic studies (family members only, this is also covered under 96-M-0060, Dr. Ellen Sidransky).
A study of obstetrical records of COS probands indicated no increase in adverse pre or perinatal events for these cases compared with obstetrical records of their siblings (Nicolson et al submitted). In contrast, several findings point to increased risk for these probands. To date, a total of 5 (10.4%) COS subjects were found to have previously unknown cytogenetic abnormalities (Microdeletion of 22q11 (3 cases), (Usiskin et al, submitted), Mosaic 45X0 (one case) (Kumra et al, 1998) and balanced 1:7 translocation (Gordon et al 1994).
The study of first degree relatives of these very rare cases addresses the hypothesis that risk factors, most probably genetic, are increased in immediate family members relative both to community controls and to the relatives of patients with chronic, treatment resistant, adult-onset schizophrenia (AOS). A second hypothesis is that COS familial risk factors show significant relationship to the developmental delays/abnormalities being observed in the COS probands. As a total of 50 additional COS subjects will be studied over the next 5 years, the pediatric control sample for the probands will also be increased, determined by the need to have concurrent measures for patients and controls to maintain measurement validity. Thus a total of 600 additional subjects are to be studied including 50 controls for COS probands, 150 COS relatives, 150 controls for COS relatives, and 250 relatives of adult onset schizophrenics (AOS).
- Sponsoring Institute:
-
National Institute of Mental Health (NIMH)
- Recruitment Detail
- Type:
Participants currently recruited/enrolled
- Gender:
Male & Female
- Referral Letter Required:
No
- Population Exclusion(s):
None
- Eligibility Criteria:
INCLUSION CRITERIA:
Inclusion criteria for healthy controls will continue to be:
Ages 6-70.
Evidence of normal developmental history and normal functioning.
Inclusion criteria for relatives of probands will continue to be:
Ages 6-65.
Evidence of blood relationship to proband with a disorder under study, with usual selection of first-degree relatives.
EXCLUSION CRITERIA:
Exclusion criteria for community controls are:
Evidence of medical or neurological disease.
Diagnosis of schizophrenia or schizoaffective disorder ?--? or in first degree relatives by history, clinical interview, or by structured, diagnostic psychiatric interview (Diagnostic Interview for Children and Adolescents-IV).
Exclusion criteria for relatives of probands:
Absence of consent on the part of the proband or parent(s) of proband to contact relatives.
Absence of signed consent or assent by relative(s) to participate.
- Special Instructions:
This is not a treatment protocol.
- Keywords:
-
Normal Controls
-
Psychophysiological
-
Neuropsychological
-
Biochemical
-
Psychological Measures
-
Immunological
-
Physiology
-
Eye Movements
-
Family Studies
-
Schizophrenia
- Recruitment Keyword(s):
-
None
- Condition(s):
-
Healthy
-
Schizophrenia
- Investigational Drug(s):
- None
- Investigational Device(s):
- None
- Intervention(s):
- None
- Supporting Site:
- National Institute of Mental Health
- Contact(s):
-
Maureen Tobin
National Institutes of Health Building 10 Room 4C110 10 Center Drive Bethesda, Maryland 20892 Phone: (301) 435-4518 Fax: (301) 480-8898 Electronic Address: adair@box-a.nih.gov
- Citation(s):
-
Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder
-
Pubertal development and onset of psychosis in childhood onset schizophrenia
-
Autonomic nervous system markers of psychopathology inchildhood-onset schizophrenia
If you have:
Search The Studies | Help | Questions | Clinical Center Home | NIH Home
National Institutes of Health Clinical Center
Bethesda, Maryland 20892. Last update: 01/13/2009
|
|